The preeminent event of its kind for compounding professionals, providing the latest in compounding regulatory guidance for ever-changing quality standards.
Prompt Praxis Laboratories was proud to participate in the 2026 Drive Excellence in Compounding Compliance and Quality Standards conference, held June 9-10 at the Hilton Philadelphia at Penn’s Landing. Dr. Lisa McChesney-Harris, CEO and Founder of PPL, joined Jaclyn Jaskowiak, PharmD, BCPS, BCSCP, and Tyler Chamberlain for the session, “Interpreting and Implementing USP 795, 797 & 800: Progress, Pitfalls & Practical Lessons.” The discussion explored how compounders are adapting to evolving USP standards, what “inspection ready” looks like in practice, and where common compliance risks can arise across training, documentation, environmental controls, quality systems, and facility workflows. Dr. McChesney-Harris also shared practical insight into stability-indicating assays, USP monograph methods, chromatographic separation concepts, and defensible approaches for evaluating compounded preparations with variable formulations.
Watch the session overview to learn more about the practical lessons, compliance considerations, and stability testing concepts discussed during this timely industry presentation.
